BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 19737531)

  • 1. Early growth response-1 is involved in foam cell formation and is upregulated by the TLR9-MyD88-ERK1/2 pathway.
    Kim JS; Park DW; Lee HK; Kim JR; Baek SH
    Biochem Biophys Res Commun; 2009 Dec; 390(2):196-200. PubMed ID: 19737531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation.
    Lee JG; Lim EJ; Park DW; Lee SH; Kim JR; Baek SH
    Cell Signal; 2008 Dec; 20(12):2266-75. PubMed ID: 18817866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
    He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
    J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway.
    Bea F; Puolakkainen MH; McMillen T; Hudson FN; Mackman N; Kuo CC; Campbell LA; Rosenfeld ME
    Circ Res; 2003 Mar; 92(4):394-401. PubMed ID: 12600889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 9 mediates CpG-DNA signaling.
    Chuang TH; Lee J; Kline L; Mathison JC; Ulevitch RJ
    J Leukoc Biol; 2002 Mar; 71(3):538-44. PubMed ID: 11867692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG oligonucleotides induce an immune response of odontoblasts through the TLR9, MyD88 and NF-kappaB pathways.
    He W; Yu Q; Zhou Z; Wang P
    Biochem Biophys Res Commun; 2010 Aug; 399(2):274-8. PubMed ID: 20655295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
    Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
    Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge.
    Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L
    Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation.
    Abdel-Malak NA; Mofarrahi M; Mayaki D; Khachigian LM; Hussain SN
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):209-16. PubMed ID: 19112164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CpG-ODN on gene expression in formation of foam cells.
    Li K; Wan B; Hu ZL; He Y; He XW; Jiang L; Sun SH
    Acta Pharmacol Sin; 2005 Nov; 26(11):1359-64. PubMed ID: 16225759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific siRNA downregulated TLR9 and altered cytokine expression pattern in macrophage after CpG DNA stimulation.
    Qiao B; Li B; Yang X; Zhang H; Chu Y; Wang Y; Xiong S
    Cell Mol Immunol; 2005 Apr; 2(2):130-5. PubMed ID: 16191419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of toll-like receptor-9 induces matrix metalloproteinase-9 expression through Akt and tumor necrosis factor-alpha signaling.
    Lim EJ; Lee SH; Lee JG; Chin BR; Bae YS; Kim JR; Lee CH; Baek SH
    FEBS Lett; 2006 Aug; 580(18):4533-8. PubMed ID: 16870179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction.
    Honda K; Ohba Y; Yanai H; Negishi H; Mizutani T; Takaoka A; Taya C; Taniguchi T
    Nature; 2005 Apr; 434(7036):1035-40. PubMed ID: 15815647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression.
    Griebel PJ; Brownlie R; Manuja A; Nichani A; Mookherjee N; Popowych Y; Mutwiri G; Hecker R; Babiuk LA
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):11-6. PubMed ID: 16098606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 induction of Egr-1 expression in INS-1 beta-cells: interaction of SRF, not YY1, with SRE site of rat Egr-1 promoter.
    Kim MJ; Kang JH; Chang SY; Jang HJ; Ryu GR; Ko SH; Jeong IK; Kim MS; Jo YH
    J Cell Biochem; 2008 Aug; 104(6):2261-71. PubMed ID: 18446785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avian-specific TLRs and downstream effector responses to CpG-induction in chicken macrophages.
    Ciraci C; Lamont SJ
    Dev Comp Immunol; 2011 Mar; 35(3):392-8. PubMed ID: 21095203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toll-like receptor 9 in cpG oligodeoxynucleotides-induced species-specific immune responses].
    Li N; Fan XG; Tang SE; Zhu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):533-5. PubMed ID: 16320582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-alpha release.
    Wang L; Jiang W; Ding G; Cao H; Lu Y; Luo P; Zhou H; Zheng J
    Int Immunopharmacol; 2007 May; 7(5):646-55. PubMed ID: 17386412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88.
    Senn JJ; Burel S; Henry SP
    J Pharmacol Exp Ther; 2005 Sep; 314(3):972-9. PubMed ID: 15919763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human lung cancer cells express functionally active Toll-like receptor 9.
    Droemann D; Albrecht D; Gerdes J; Ulmer AJ; Branscheid D; Vollmer E; Dalhoff K; Zabel P; Goldmann T
    Respir Res; 2005 Jan; 6(1):1. PubMed ID: 15631627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.